HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Revenue

HLB Life Science had revenue of 14.66B KRW in the quarter ending June 30, 2026, with 24.53% growth. This brings the company's total for the last twelve months to 54.40B, up 37.87% year-over-year. In the year 2025, HLB Life Science had annual revenue of 45.75B with 39.61% growth. That makes HLB Life Science the 29,363rd largest company in the world by revenue and 1,814th in South Korea.

• Revenue (ttm): 54.40B
• Revenue Growth: +37.87%
• P/S Ratio: 7.48
• Revenue / Employee: 353.24M
• Employees: 154
• Market Cap: 399.66B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicare Division 35.13B 74.8%
• Other 6.10B 13.0%
• Construction and Engineering 5.35B 11.4%
• Bio Development 358.95M 0.8%

By Geography

Chart

• South Korea 40.61B 88.8%
• Foreign Country 5.14B 11.2%

Fiscal year ended Dec 31, 2025 See the full HLB Life Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	45.75B	12.98B	39.61%
Dec 31, 2024	32.77B	-65.22B	-66.56%
Dec 31, 2023	97.99B	-1.60B	-1.61%
Dec 31, 2022	99.59B	46.10B	86.17%
Dec 31, 2021	53.49B	-38.30B	-41.73%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error